Second-Sourcing Your Autoinjector: A Procurement Playbook for Device Teams
Published 2026-10-27 · Keywords: second source autoinjector
A second source for an autoinjector is not found at quotation stage — it is qualified against the incumbent’s device, container and documentation set, and the qualification takes longer than the first order. Plan it in three phases: technical match, documentation match, and a bridge batch. Teams who start after a supply disruption have none of the three.
Why second-sourcing a device is harder than second-sourcing a drug
The drug is a molecule; the device is a force chain. A replacement autoinjector must match the incumbent’s container interface (barrel tolerance, flange geometry, stopper friction), its activation behaviour (force, travel, end-of-dose signal) and its user-facing characteristics closely enough that your human-factors evidence still holds. Two devices can both “meet ISO 11608-5” and still feel different in the hand.
| Phase | What happens | Typical artefacts | Watch for |
|---|---|---|---|
| 1. Technical match | Dimensional and force-chain comparison against your container | Fit report, break-loose / glide force summary — values per program | Syringe supplier named by you, not assumed by the vendor |
| 2. Documentation match | Certificates, test reports and material declarations mapped to your file | ISO 13485 scope text, ISO 11608 part reports, biocompatibility data | Scope covering finished devices, not components |
| 3. Bridge batch | Limited run built and verified against your container | Functional delivery summary, retained samples | Sterilization load minimums setting the batch size |
The timeline question every team asks
Durations are program-specific: sample, validation and sterilization release times vary by platform and container. What can be stated generally: the bridge batch, not the sample, is the long pole. Samples prove the design; the bridge batch proves the process, and it carries the same qualification cost as a production run.
How to verify a candidate second source
Ask three questions in writing. One: does your ISO 13485 scope text cover finished devices — quote it. Two: will you verify compatibility against our named syringe supplier before the order, and hand us the force-chain numbers? Three: what does a bridge batch cost and contain? A supplier who answers all three without a call has done this before.
What this does not cover
Switching costs in your regulatory submission — device-change notifications, comparability evidence and human-factors deltas are your RA team’s territory. This playbook covers the device-supply side: match, documents and bridge.
Next step: send the incumbent device’s container format and your annual volume — we return a second-source feasibility answer with the verification plan inside one working day. Start the inquiry.
Related reading
Talk to NOVIXPEN about your program
Send your container format, annual volume and target market — we reply with the platform match, documentation set and written quotation within one working day.
Start the inquiry